KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $37,000 | -7.5% | 10,875 | +2.4% | 0.00% | – |
| Q2 2018 | $40,000 | -4.8% | 10,615 | +2.2% | 0.00% | – |
| Q1 2018 | $42,000 | -12.5% | 10,385 | 0.0% | 0.00% | – |
| Q4 2017 | $48,000 | -35.1% | 10,385 | 0.0% | 0.00% | – |
| Q3 2017 | $74,000 | +1.4% | 10,385 | +2.9% | 0.00% | – |
| Q2 2017 | $73,000 | +17.7% | 10,095 | 0.0% | 0.00% | – |
| Q1 2017 | $62,000 | +5.1% | 10,095 | 0.0% | 0.00% | – |
| Q4 2016 | $59,000 | +9.3% | 10,095 | 0.0% | 0.00% | – |
| Q3 2016 | $54,000 | +8.0% | 10,095 | -5.1% | 0.00% | – |
| Q1 2016 | $50,000 | -7.4% | 10,635 | 0.0% | 0.00% | – |
| Q4 2015 | $54,000 | +42.1% | 10,635 | -0.9% | 0.00% | – |
| Q3 2015 | $38,000 | -63.8% | 10,735 | +1.9% | 0.00% | – |
| Q2 2015 | $105,000 | -22.2% | 10,535 | -0.9% | 0.00% | – |
| Q1 2015 | $135,000 | -5.6% | 10,635 | +4.9% | 0.00% | – |
| Q4 2014 | $143,000 | +2.9% | 10,135 | 0.0% | 0.00% | – |
| Q3 2014 | $139,000 | -52.4% | 10,135 | -46.7% | 0.00% | -100.0% |
| Q2 2014 | $292,000 | – | 18,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |